Provided by Tiger Fintech (Singapore) Pte. Ltd.

Catalyst Pharmaceuticals

21.28
-0.1702-0.79%
Volume:308.28K
Turnover:6.59M
Market Cap:2.60B
PE:13.57
High:21.70
Open:21.64
Low:21.21
Close:21.45
Loading ...

Catalyst Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Catalyst: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
27 Feb

Catalyst Pharmaceuticals reports Q4 EPS 70c, consensus 55c

TIPRANKS
·
27 Feb

Catalyst Pharmaceuticals sees FY25 revenue $545M-$565M, consensus $558.08M

TIPRANKS
·
27 Feb

Stock Track | Catalyst Pharmaceuticals Soars 8.14% After Hours on Stellar Q4 Results and 2025 Outlook

Stock Track
·
27 Feb

Catalyst Pharmaceuticals Q4 2024 Adj EPS $0.70 Beats $0.34 Estimate, Sales $141.81M Beat $134.20M Estimate

Benzinga
·
27 Feb

Catalyst Pharmaceuticals Shares up 8% After the Bell Following Results, Outlook

THOMSON REUTERS
·
27 Feb

BRIEF-Catalyst Pharmaceuticals FY Revenue USD 491.7 Million Vs. IBES Estimate USD 484.1 Million

Reuters
·
27 Feb

Catalyst Pharmaceuticals Inc: Q4 Adj EPS $0.70

THOMSON REUTERS
·
27 Feb

Corrected-Catalyst Pharmaceuticals FY Adjusted Net Income USD 276.3 Million

THOMSON REUTERS
·
27 Feb

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
27 Feb

Should Janus Henderson Small Cap Growth Alpha ETF (JSML) Be on Your Investing Radar?

Zacks
·
25 Feb

Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
25 Feb

Catalyst Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
19 Feb

Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 374%

Simply Wall St.
·
17 Feb

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
14 Feb

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

GlobeNewswire
·
12 Feb

Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
07 Feb

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
05 Feb